Clinical Trial Update: A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating BL-B16D1 in patients with unresectable locally advanced or metastatic breast cancer and other solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Solid Tumor

Drugs mentioned

• BL-B16D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Breast Cancer, Solid Tumor | Phase 1 | Status: RECRUITING